MedPacto, Inc. (KOSDAQ:235980)
South Korea
· Delayed Price · Currency is KRW 5,280.00
-210.00 (-3.83%)
Apr 29, 2026, 3:30 PM KST
MedPacto Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 3,898 | - | - | - | - | Upgrade
|
| Cost of Revenue | 3,513 | - | - | - | - | Upgrade
|
| Gross Profit | 385.16 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 4,052 | 3,613 | 4,427 | 5,021 | 4,607 | Upgrade
|
| Research & Development | 10,138 | 18,018 | 24,164 | 31,919 | 24,551 | Upgrade
|
| Amortization of Goodwill & Intangibles | 67.21 | 50.78 | 49.36 | 44.08 | 31.76 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 12.46 | Upgrade
|
| Operating Expenses | 14,429 | 21,807 | 28,752 | 37,246 | 29,459 | Upgrade
|
| Operating Income | -14,044 | -21,807 | -28,752 | -37,246 | -29,459 | Upgrade
|
| Interest Expense | -117.31 | -91.94 | -493.23 | -9,621 | -7,769 | Upgrade
|
| Interest & Investment Income | 1,239 | 1,687 | 388.46 | 1,324 | 663.52 | Upgrade
|
| Earnings From Equity Investments | - | - | -390.44 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -17 | -116.09 | 114.09 | 25.05 | -19.66 | Upgrade
|
| Other Non Operating Income (Expenses) | 199.32 | 85.4 | 64.07 | 9,272 | 19,278 | Upgrade
|
| EBT Excluding Unusual Items | -12,740 | -20,243 | -29,069 | -36,246 | -17,306 | Upgrade
|
| Gain (Loss) on Sale of Investments | -47.37 | 102.2 | 350.51 | 492.28 | 266.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | -23.57 | - | -5.93 | - | - | Upgrade
|
| Other Unusual Items | - | - | -6,600 | - | - | Upgrade
|
| Pretax Income | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 | Upgrade
|
| Net Income | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 | Upgrade
|
| Net Income to Common | -12,811 | -20,140 | -35,325 | -35,753 | -17,040 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 21 | 33 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 21 | 33 | 20 | Upgrade
|
| Shares Change (YoY) | 1.70% | 58.73% | -36.20% | 62.45% | 0.88% | Upgrade
|
| EPS (Basic) | -374.00 | -598.00 | -1664.87 | -1075.00 | -832.30 | Upgrade
|
| EPS (Diluted) | -374.00 | -598.00 | -1665.00 | -1075.00 | -832.30 | Upgrade
|
| Free Cash Flow | -13,481 | -16,873 | -26,402 | -30,491 | -25,909 | Upgrade
|
| Free Cash Flow Per Share | -393.57 | -500.99 | -1244.33 | -916.79 | -1265.52 | Upgrade
|
| Gross Margin | 9.88% | - | - | - | - | Upgrade
|
| Operating Margin | -360.24% | - | - | - | - | Upgrade
|
| Profit Margin | -328.61% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -345.80% | - | - | - | - | Upgrade
|
| EBITDA | -12,888 | -20,265 | -26,919 | -35,380 | -27,736 | Upgrade
|
| D&A For EBITDA | 1,156 | 1,542 | 1,833 | 1,866 | 1,723 | Upgrade
|
| EBIT | -14,044 | -21,807 | -28,752 | -37,246 | -29,459 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.